Maynard Um
-
-
-
-
-
-
-
Raymond James on Viking Therapeutic (VKTX): 'Our analysis of this dataset suggests semaglutide does not have a lean body mass preservation advantage'
-
-
-
-
-
-
-
Viking Therapeutic (VKTX) PT Lowered to $118 at Raymond James
-
-
-
-
-
-
-
Viking Therapeutic (VKTX) PT Raised to $107 at Canaccord Genuity
-
-
-
-
-
-
-
Viking Therapeutics (VKTX) Misses Q3 EPS by 11c
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Viking Therapeutic (VKTX)
-
-
-
-
-
-
-
H.C. Wainwright Keeps PT at $102 on Viking Therapeutic (VKTX), 'Varying Sentiments Flying Around, But We Are Happy
-
-
-
-
-
-
-
Mizuho: Viking (VKTX) Oral Obesity Program is 'Quite Discouraging'
-
418,488 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

